A Gisborne health board member has been reprimanded after posting misinformation about the Covid-19 vaccine on social media.
Hauora Tairāwhiti board member Meredith Akuhata-Brown, who is also a Gisborne district councillor, said New Zealanders were being asked to take a vaccine that had not been "effectively trialled" or "met any real Medsafe approval".
Medsafe approved the Pfizer BioNTech Covid-19 vaccine before it was signed off for use by Cabinet on February 10.
Associate Health Minister Peeni Henare wasn't impressed.
"I am disappointed because we know that as a Government and as a health system we've got a job to work with our communities in respect to Covid-19 as well as the vaccine," he said.
"The questions that people have are relevant, and we're able to answer them, so to have speculation in our community isn't helpful when we're trying to give correct information."
Hauora Tairāwhiti chair Kim Ngarimu said she was disappointed to see this sentiment expressed by a board member. She had discussed it with Akuhata-Brown.
"The post most definitely does not reflect the DHB's position," Ngarimu said.
The health board in October last year reported that misinformation and rumours about vaccinations were affecting Tairāwhiti's immunisation rates.
Hauora Tairāwhiti in January recorded the country's lowest rates of immunisation of children at eight months, with 78.8 per cent receiving all shots on time in the previous quarter.
Meredith Akuhata-Brown's post to Facebook on April 6.
In the post to Facebook on April 6, Akuhata-Brown said the Government didn't fund many cancer drugs, but the Pfizer vaccine was free.
She called for "informed consent" and "more transparency" around the vaccine.
Akuhata-Brown told Local Democracy Reporting the post was intended to question why the world could react with such swiftness to the Covid-19 pandemic, and "push aside" other issues such as homelessness and poverty.
"My challenge to this space is, is this all about money again?"
Akuhata-Brown said she was not posting as an elected member of the health board or council, despite it being made from a public page called "Meredith Akuhata Brown for Participatory Democracy".
"I don't speak on behalf of any of those roles ... this is Meredith Akuhata-Brown who was thinking about something and posted, so admittedly it does pose concerns when I am in positions like I am. But I believe half the time I was elected because of the way I think, the way I question things."
She posted after hearing NZ Outdoors Party co-leader Sue Grey discussing the vaccine on talkback radio, and said she should have made that clear.
Grey wrote to Prime Minister Jacinda Ardern on March 31 claiming the rollout of the vaccine was illegal.
"I still want to legitimately ask these questions. I still have these questions," Akuhata-Brown said.
But she clarified she was not promoting an anti-vaccination stance.
"That would be wrong of me based on my role and the vulnerable communities I serve. I'm promoting information sharing."
Henare is scheduled to visit Tairāwhiti next week as part of a national "roadshow" to convince Kiwis, in particular Māori communities, to be vaccinated against Covid-19.
This includes visiting marae and having hui to answer questions about Covid-19 and the vaccine, face to face.
A Covid-19 sign at the entrance to Gisborne Hospital. Photo / Liam Clayton, LDR
He believed the Government was doing enough to communicate information about the vaccine, he said. This would include a vaccine campaign targeted at Māori communities to be released over the next 10 days.
"One of the things that we lean on as a Government are the likes of the DHB and our local health providers to be able to provide that information correctly and directly to our people," he said.
Hauora Tairāwhiti medical officer of health Dr Osman David Mansoor said the vaccine had received provisional approval under Section 23 of the Medicines Act.
This was based on the large, randomised control trial of more than 40,000 people and subsequent real-world data with millions of doses of the vaccine being given every day.
Mansoor said to date, no safety concerns had emerged about the Pfizer vaccine.
"It is proving to be as effective in protecting people as found in the trial.
"Evidence is also emerging that it is nearly as effective at preventing infection as at preventing disease, so we can expect the vaccine to prevent spread too," he said.
